Cleveland BioLabs Announces Commencement of In Vivo Biocomparability Study - Seite 3
Contacts:
Cleveland BioLabs, Inc.
C. Neil Lyons
Chief Financial Officer
T: 301-675-4570
E: nlyons@cbiolabs.com